Discovery of IAP-Recruiting BCL-X(L) PROTACs as Potent Degraders across Multiple Cancer Cell Lines

Targeting BCL-X(L) via PROTACs is a promising strategy in reducing BCL-X(L) inhibition associated platelet toxicity. Recently, we reported potent BCL-X(L) PROTAC degraders that recruit VHL or CRBN E3 ligase. However, low protein expression or mutation of the responsible E3 ligase has been known to r...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Med Chem
Autors principals: Zhang, Xuan, He, Yonghan, Zhang, Peiyi, Budamagunta, Vivekananda, Lv, Dongwen, Thummuri, Dinesh, Yang, Yang, Pei, Jing, Yuan, Yaxia, Zhou, Daohong, Zheng, Guangrong
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7325632/
https://ncbi.nlm.nih.gov/pubmed/32388279
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejmech.2020.112397
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars